(19)
(11) EP 1 381 365 A1

(12)

(43) Date of publication:
21.01.2004 Bulletin 2004/04

(21) Application number: 02757820.2

(22) Date of filing: 28.03.2002
(51) International Patent Classification (IPC)7A61K 31/496, C07D 409/14
(86) International application number:
PCT/US2002/009445
(87) International publication number:
WO 2002/078707 (10.10.2002 Gazette 2002/41)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 29.03.2001 US 279610 P
29.03.2001 US 279592 P

(71) Applicant: SmithKline Beecham Corporation
Philadelphia, PA 19103 (US)

(72) Inventors:
  • DHANAK, Dashyant
    King of Prussia, PA 19406-0939 (US)
  • KNIGHT, Steven, D.
    King of Prussia, PA 19406-0939 (US)
  • JIN, Jian
    King of Prussia, PA 19406-0939 (US)
  • RIVERO, Ralph, A.
    King of Prussia, PA 19406-0939 (US)
  • SAPIENZA, Anthony
    West Chester, PA 19380 (US)

(74) Representative: Hockley, Siân Catherine et al
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) PYRROLIDINE SULFONAMIDES